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I. Introduction
T he dietary supplement industry has been quite the buzz inthe past few years. The supplement industry is massive-
almost half of the American population consumes dietary
supplements every year'-and views regarding the industry could
not be more disparate. Some scorn supplement manufactures as
being unregulated Wild West bandits who take advantage of a
lax regulatory system in order to beguile innocent consumers into
spending a fortune on ineffective snake-oil-like products. Not
only are supplements accused -of being ineffective, but it also
seems that newspapers are all too often filled with lurid headlines
regarding untimely deaths resulting from deleterious dietary
supplement consumption. On the flip side, dietary supplement
manufacturers and many consumers believe that supplements are
a great way to improve one's physical and emotional well-being.
By having access to a broad range of dietary supplements,
consumers can determine for themselves what areas of life they
I J.D. Candidate, The University of Texas School of Law, May 2011; B.A.
in Psychology, magna cum laude, College Honors, Departmental Honors, The
University of California at Los Angeles, 2008. I would like to thank Professor
Thomas McGarity for his assistance throughout the writing process.
2 Press Release, Council for Responsible Nutrition, New Industry
Initiative Targets Deceptive, False and Misleading Dietary Supplement
Advertising,
http://www.crnusa.org/pdfs/CRNNADNewAdvertisingInitiative.pdf (last
visited Sept. 21, 2010) [hereinafter New Industry Initiative].
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would like to improve and can tailor a specific dietary
supplement regime to meet their individual needs. Whether one
wants to lose weight, needs more energy, or desires an all-natural
method of lowering blood pressure, the supplement industry can
provide an effective and relatively easy regime to help consumers
achieve their individual goals.
So who's right? Are dietary supplements really so out of
control and harmful to U.S. consumers that individuals should
grab a tight hold of their pocket books and run whenever they see
an advertisement for a weight loss supplement? Or should
Americans embrace supplements as being a relatively cheap and
easy way to increase one's health and physical well-being? Do we
need a massive regulatory overhaul to protect American
consumers?
The evidence shows that while supplements do provide
many benefits, the current regulatory system in place does in fact
leave the public vulnerable to substantial risk. The Food and
Drug Administration ("FDA"), the Federal Trade Commission
("FTC"), and the National Advertising Division ("NAD") employ
a variety of regulatory and enforcement measures to combat
unscrupulous supplement companies. However, while the
agencies provide a robust regulatory regime, it is currently
insufficient to fully protect consumers from deleterious products
and misleading advertisements. Fortunately, there are several
relatively inexpensive and minimally burdensome measures that
the FDA and FTC can take to substantially augment consumer
protection.
This article will analyze the strengths and weaknesses of
the current regulatory system in place to protect consumers and
will suggest several methods of improvement. While this essay
will tangentially touch on the issues of foreign product regulation
and importation, a robust discussion of international regulation is
complex-such a discussion would require an in-depth analysis of
the United States' relationships with several foreign nations-
and is beyond the scope of this article. Instead, this article will
focus on one of the most fundamental requirements necessary to
establish a safe supplement industry: domestic regulation. The
United States faces a sizeable challenge with simply monitoring
and regulating domestically produced supplements that are
marketed to U.S. consumers. Before we can focus our efforts
abroad, we must first ensure that we have established quality
practices at home.
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A. What is a Dietary Supplement?
Congress defines the term' "dietary supplement" in the
Dietary Supplement Health and Education Act ("DSHEA").
According to the DSHEA, a dietary supplement is a product
taken by mouth that contains a dietary ingredient.4 Dietary
ingredients include: vitamins, minerals, herbs or other botanicals,
amino acids, dietary substances used to supplement the diet by
increasing the total dietaiy intake, or concentrates, metabolites,
constituents, and extracts.' Dietary supplements can exist in a
variety of forms such as tablets, liquids, powders, or bars.
Furthermore, the DSHEA classifies dietary supplements as foods,
not drugs.' This distinction has important implications for how
dietary supplements are regulated under the DSHEA.
B. What is the DSHEA?
The DSHEA was signed into law by President Clinton in
October of 1994 and it created a new regulatory framework for
the safety and labeling of dietary supplements." Under the
DSHEA, - the company who manufactures the dietary
supplement, not the FDA, is responsible for determining if the
supplement is safe. 9 The manufacturing company is also
responsible for determining that the claims it makes about the
supplement are true and not misleading.10 The implications of
these two rules are substantial: in most cases, dietary supplements
do not need prior approval by the FDA before they reach the
market." Consequently, companies are free to manufacture and
Press Release, U.S. Food and Drug Administration, Overview of Dietary
Supplements,
http://www.fda.gov/Food/DietarySupplements/Consumerlnformation/ucm 110
417.htm (last modified Oct. 14, 2009) [hereinafter Overview of Dietary
Supplements].
4 21 U.S.C. § 321(ff) (2009).
Id.
6 Overview of Dietary Supplements, supra note 3.
7 21 U.S.C. § 321 (ff) (2009).
s Overview of Dietary Supplements, supra note 3.
* 21 U.S.C. § 343(r)(6) (2010).
10 Id.
" Overview of Dietary Supplements, supra note 3 (stating that dietary
supplements will not need prior approval by the FDA as long as the
supplement does not contain a "new dietary ingredient." A new dietary
ingredient is defined in the DSHEA as an ingredient that was not sold in the
U.S. as a dietary supplement before October 15, 1994. If the supplement
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sell dietary supplements at their own discretion. While a
company is still required to have evidence to substantiate the
claims it makes, the company is not required to provide any of
the data to the FDA before the supplement is sold to the public.
This means that there is essentially no barrier between an
unscrupulous dietary supplement manufacturer and the public.
Congress deliberately made this policy decision. When
passing the DSHEA, Congress' goal was to increase the public's
access to dietary supplements in order to promote the general
wellness of the American population.1 2 Congress believed that
there may be a positive relationship between dietary supplement
use and disease prevention, and that supplement use positively
correlated with reduced health-care expenses." By eliminating
the regulatory burdens placed on the dietary supplement
industry, Congress believed that it had created an effective and
inexpensive method of simultaneously keeping Americans
healthy while saving them money.
The easy-access policy was sure to be a hit with the
American population. The dietary supplement industry in the
United States is enormous. Over a thousand manufactures
market over 29,000 supplement products, creating a $20 billion
industry.14 And the industry is not simply composed of a niche
class of individuals, such as bodybuilders or health gurus. Over
150 million Americans consume dietary supplements every year. 5
With a total population of just over 300 million, that means about
half. of the entire American population uses dietary supplements
every year.'" With such a widespread popularity, Congress was
surely going to craft a policy that would allow relatively easy
access to supplements. Disappointing 150 million Americans
would be political suicide. On top of that, the $20 billion dollar
contains a new dietary ingredient the product requires pre-approval by the
FDA before marketing. The manufacturer must notify the FDA of its
intentions to sell the new dietary ingredient and must either demonstrate why
the ingredient is expected to be safe or show that the ingredient has been
recognized as a food substance and is present in the food supply).
12 Nutraceutical Corp. v. Von Eschenbach, 459 F.3d 1033, 1038 (10th Cir.
2006); Pharmanex v. Shalala, 221 F.3d 1151, 1158-59 (10th Cir. 2000).
" Nutraceutical Corp., 459 F.3d at 1038; Pharmanex, 221 F.3d at 1158-59.
14 Lars Noah & Barbara A. Noah, A Drug by any Other Name...?:
Paradoxes in Dietary Supplement Risk Regulation, 17 STAN. L. & POL'Y REV.
165, 165 (2006).
15 New Industry Initiative, supra note 2.
16 Press Release, U.S. Census Bureau, Data Finders,
http://www.census.gov/ (last visited Sept. 21, 2010).
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supplement industry has tremendous clout with Congress and
would fervently oppose any type of policy that might infringe on
the industry's profits. The easy-access policy seemed to be ideal:
Congress could create an effective, inexpensive policy that was
popular with both corporate America and the general population.
Such a policy, when implemented properly, can have
many benefits. Supplements can indeed promote the general
wellness of the population at a relatively cheap price. As long as
supplements are labeled and advertised accurately, dietary
supplements are a great addition to the food supply: Americans
can decide what types of supplements will be the most beneficial
for their own wellness goals. Americans can rely on the labeling
and advertisements of supplements to tailor specific programs to
their individual lifestyles. However, the crucial factor is that
supplements must be labeled and advertised accurately. If
misleading, supplements can be extremely pernicious to the
average American. For example, supplements might hurt
Americans by convincing them to spend money on snake-oil-like
products that have no benefits at all. Even worse, some products
that purport to be safe might be seriously deleterious to the
consumer. Therefore, the success or failure of the DSHEA's easy-
access policy relies on the validity and accuracy of advertisement
claims. There are several public and private institutions that exist
to ensure the supplement industry accurately and truthfully
advertises its products to the public. These government agencies
and private regulatory institutions combine to create a robust
regulatory force, but unfortunately, their efforts are insufficient to
effectively police the entire supplement industry. Consequently,
the DSHEA's easy-access policy is leaving supplement consumers
vulnerable to health and pecuniary risks, and several policy
changes need to be implemented in order to remedy the
predicament.
II. Regulation and Enforcement of Dietary Supplement
Advertising
A. Government Regulation
The Federal Government regulates food supplements
using a combination of agencies. Under a longstanding liaison
agreement, the FDA and FTC have shared jurisdiction over the
food supplement industry: the FDA is responsible for the labeling
58 [Vol. 23:1
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of supplements and the FTC is responsible for policing
advertisements." Courts have interpreted the term "labeling"
very broadly, so it does not strictly refer to the actual labels on
containers. The term "labeling" includes any materials distributed
at the point of sale, and thus the FDA has jurisdiction over audio
and visual displays, or inserts or promotional materials
distributed at the point of sale." The FTC, on the other hand, is
responsible for regulating all non-labeling advertising claims.
Thus, the FTC is responsible for regulating advertisements made
through a variety of media sources, including print and broadcast
advertisements, infomercials, websites, catalogs, and similar
direct marketing materials." The two agencies work closely
together to ensure that their policies are consistent.2 0 In fact, the
FDA is so deeply intertwined with the FTC that it is essentially
impossible to give a thorough analysis of consumer protection
against misleading supplement claims without discussing. the role
of both agencies.
1. Food and Drug Administration
a. FDA Regulatory and Enforcement Action
While the FDA's official jurisdiction is limited to labeling,
the agency in fact takes broad action to police unscrupulous
dietary supplement manufacturers. The FDA's role consists of a
wide range of enforcement, surveillance, and prophylactic
measures.
The FDA can combat potentially dangerous supplements
in a variety of ways. If the FDA deems a supplement to be a
potentially serious threat, it can pursue several judicial or
administrative courses of action.21 The agency's most powerful
1 Press Release, Federal Trade Commission, Business Guide For Dietary
Supplement Industry Released by FTC Staff,
http://www.ftc.gov/opa/1998/11/dietary.shtm (last modified Nov. 18, 1998)
[hereinafter FTC Business Guide].
" John E. Villafranco & Andrew B. Lustigman, Regulation of Dietary
Supplement Advertising: Current Claims of Interest to the Federal Trade
Commission, Food and Drug Administration, and Nation Advertising
Division, 62 FOOD & DRUG L.J. 709, 711 (2007).
* Id.
20 FTC Business Guide, supra note 17.
21 UNITED STATES GOVERNMENT ACCOUNTABILITY OFFICE, REPORT TO
CONGRESSIONAL REQUESTERS, DIETARY SUPPLEMENTS: FDA SHOULD TAKE
FURTHER ACTIONS TO IMPROVE OVERSIGHT AND CONSUMER
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tool is its ability to institute a complete product ban.22 However,
while the ability to institute a complete ban is immensely
powerful, it is rarely used and is ultimately a fairly impractical
enforcement mechanism. Since the DSHEA's enactment, the
FDA has only successfully banned one dietary supplement,
ephedra.3 Ephedra had been linked to numerous deaths24 and
over 16,000 adverse events25 during the years that it was legally
sold to U.S. consumers. However, despite the overwhelming
evidence against ephedra, it still took the FDA nearly ten years to
ban the ingredient from the market.26 Long and costly legal
battles, coupled with the fact that the FDA has the burden of
proving that a product poses a "significant or unreasonable risk"
to consumer health, makes instituting a complete product ban a
tremendously onerous and expensive endeavor. Consequently,
the FDA has developed other methods of policing the supplement
industry. First, the FDA can attempt to persuade a company to
voluntarily recall its supplement.2 8 While the FDA does not have
mandatory recall authority, it has been successful at convincing
several companies to voluntarily recall their products. Between
2003 and 2008, the FDA successfully worked with companies to
recall forty-five dangerous or defective dietary supplements
products that posed a serious health concern. 29 Twenty-seven of
the recalls were due to unapproved pharmaceuticals being illicitly
marketed as, or included in, dietary supplements. 30 The FDA also
has the option of pursuing legal action against the supplement
company.31 The FDA successfully obtained twenty-seven seizures
and six injunctions. between 2002 to 2008, most of which were
against supplement manufacturers who illicitly claimed that their
UNDERSTANDING, 2, http://www.gao.gov/new.items/d09250.pdf [hereinafter
GAO] (January 2009).
22 Id.
23 Id. at 20.
24 Press Release, Center for Science in the Public Interest, FDA Can't
Protect Americans from Dangerous Dietary Supplements, GAO Says,
http://www.cspinet.org/new/200903022.html (Mar. 2, 2009).
25 Online Lawyer Source, Hydroxycut Ephedra,
http://www.onlinelawyersource.com/hydroxycutlephedral (last visited Sept. 17,
2010).
26 GAO, supra note 21, at 20.
27 Id. at 17.
28 Id. at 20.
29 Id.
30 Id.
31 Id.
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supplements could treat, cure, or prevent diseases.32 The agency
also filed criminal charges and won convictions in nineteen cases
over the same time period.3 Finally, if an imported supplement
poses a serious risk to consumers, the FDA can either detain the
product or refuse to allow it into the country altogether.3 4 The
FDA detained 3,225 supplement import entry lines during the
period of 2002 to 2008, fifty percent of which were due to the
potential presence of a poisonous or unsafe substance.3 s Over the
same time period, the FDA also refused 3,604 lines of dietary
supplements by citing 5,560 violations. 36 Twenty-five percent of
the violations were due to the potential presence of an unsafe
substance.
In addition to taking judicial and administrative action,
the FDA can also rely on a medley of advisory actions to protect
consumers from deleterious supplements. For starters, the FDA
can conduct informal meetings with supplement companies in
which FDA agents speak with company executives to explain
their concerns. At the meetings, the FDA does not necessarily
attempt to compel the company to act in a certain way, nor does
the FDA collect agency-wide data; the meetings are simply
informative.39 As an alternative to actually meeting with the
company, the FDA can also issue warning letters.4 0 From 2002 to
2007, the FDA issued 293 warning letters, seventy percent of
which related to dietary supplements that the FDA deemed to be
either unapproved or misbranded drugs. 41 The FDA delivers both
physical letters and "cyber letters" to marketers of dietary
supplement products.42
The FDA also employs several surveillance mechanisms in
an attempt to gather and maintain current data concerning the
32 Id.
3 Id.
34 Id.
3s Id.
36 Id.
3 Id.
38 Id.
39 Id.
40 Id.
41 Id.
42 The Status of Dietary Supplements in the United States: Hearing Before
the Subcomm. on Human Rights and Wellness of the H. Comm. on Gov't
Reform, 103rd Cong. (March 24, 2004) (statement of Robert E. Brackett,
Director, Center for Food Safety and Applied Nutrition), available at
http://www.fda.gov/NewsEvents/Testimony/ucm114758.htm.
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supplement industry. The FDA's surveillance efforts begin at the
nation's borders. The FDA reviewed 616,464 import entry lines
of dietary supplements during the period of 2002 to 2008, and on
average either sampled or examined approximately three to five
percent of them.4 3 Within the United States, the FDA also
conducts routine facility inspections.4 The FDA worked with
state authorities to conduct 909 inspections of dietary supplement
firms from 2002 to 2008.45 Furthermore, the FDA maintains a
database of any adverse events related to supplement use.46
Between 2002 and 2008, the FDA received 1,018 consumer
complaints, forty-two percent of which (i.e., 428 complaints)
involved adverse symptoms from dietary supplements.47 The
complaints involving adverse symptoms, triggered 236 FDA
active surveillance operations, which included inspections and
sample collections. 48 The legislature attempted to improve the
accuracy of the FDA's database in 2006 with the passage of The
Dietary Supplement and Nonprescription Drug Consumer
Protection Act ("DSND Consumer Protection Act").49 The DSND
Consumer Protection Act, which went into effect in 2007,
requires supplement companies to submit any serious adverse
event reports they receive to the FDA.s0 Serious adverse events
include instances such as death, life-threatening experiences,
inpatient hospitalization, birth defects, or episodes which require
medical or surgical intervention to prevent such serious
outcomes." The DSND Consumer Protection Act, however, does
not require companies to report mild or moderate adverse events,
but they may do so voluntarily.5 2 Such mild and moderate
adverse events include afflictions such as headaches or stomach
aches.s3 Consumers and health practitioners may also.voluntarily
submit reports to the FDA concerning all types of adverse events
related to dietary supplements.5 4 The good news is that The
DSND Consumer Protection Act seems to be having a significant
" GAO, supra note 21, at 18.
44 Id.
45 Id.
46 Id. at 11.
4 Id. at 18.
48 Id.
49 Id. at 11.
so Id. at 2.
s' Id.
52 Id. at 2-3.
s3 Id.
54 Id. at 3.
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positive effect on reporting volume: since the mandatory
reporting requirement went into effect in December 2007, the
FDA has seen a threefold increase in the number of all adverse
events reported to the agency compared with the previous year.ss
Unfortunately, even with the recent passage of the DSND
Consumer Protections Act, the FDA's database is still
significantly incomplete due to underreporting. Recent FDA
estimates indicate that the actual number of annual total side
effects relating to dietary supplements-including mild,
moderate, and severe side effects-was most likely over 50,000.56
The FDA is currently trying to combat such widespread
underreporting by making the reporting process simpler and
easier to understand. The FDA has attempted to simplify the
process in two ways. First, the agency has reached out to
businesses by teaching them about the new reporting
requirements and helping them draft forms.s? Second, the FDA is
currently developing a new Internet-based reporting mechanism
called MedWatchPlus.ss With the new Internet site, the FDA
hopes to simplify the reporting process by reducing the time and
cost it takes to report adverse events. 59
Finally, in addition to its enforcement and surveillance
efforts, the FDA also attempts to protect consumers from dubious
supplements through several prophylactic measures. The FDA
aims several of these prophylactic-measures at supplement
manufacturers. In June 2007, the FDA finalized its Current Good
Manufacturing Practice ("CGMP") regulations to establish
quality control standards for dietary supplements.60 These rules
went into effect in August of 2007, but some companies,
depending on their size, had until June 2010 to become fully
compliant. 61 The CGMP regulations are intended to ensure that
ss Id. at 12.
56 Id. at 6.
s7 Id. at 12.
5 Id. at 17.
s9 Id.
60 Id. at 11.
6 Small companies have the most time to comply with the requirements.
Large companies had to comply with the requirements by June 2008,
companies with less than 500 employees had until June 2009, and companies
with less than 20 employees had until June 2010. Press Release, U.S. Food and
Drug Administration, Dietary Supplement Current Good Manufacturing
Practices (CGMPs) and Interim Final Rule (IFR) Facts, 1 (June 22, 2007),
http://www.fda.gov/Food/DietarySupplements/GuidanceComplianceRegulator
ylnformation/RegulationsLaws/ucm110858.htm (last visited Sept. 16, 2010).
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"proper controls are in place for dietary supplements so that they
are processed in a consistent manner.. .and meet quality
standards." 6 2 Such quality controls include provisions relating to
proper manufacturing operations, testing procedures, the
handling of consumer complaints, and record maintenance
procedures. Ideally, the CGMPs will help reduce the amount of
deleterious and adulterated products that reach consumers.
The FDA has also attempted to prevent harmful
exposures to pernicious supplements by targeting consumers
themselves. The FDA maintains information on its website
concerning dietary supplements and its jurisdiction over them.
The FDA's website provides clear and easy-to-understand
descriptions of how supplements are regulated in the United
States and also provides suggestions for how consumers can
avoid being scammed by unscrupulous supplement companies.64
The FDA has also distributed brochures containing similar
information.s Overall, the FDA's prophylactic measures have
sought to inform consumers about industry-related risks before
consumers are exposed to harmful products.
However, in the unhappy and all-too-frequent case where
the FDA is not able to prevent consumer harm and identifies a
deleterious supplement only after it has caused negative effects,
the agency strives to alert consumers and supplement
manufactures about the substance as quickly as possible. The
FDA has several mechanisms aimed at providing efficient and
widespread alerts in order to prevent as many exposures as
possible. For example, the FDA tries to reach consumers by
posting alerts on its website. The FDA posted twelve alerts on its
website between 1999 and 2008.66 Such alerts included warnings
about taking kava, aristolochic acid, and St. John's wort, among
others.6 7 To reach supplement companies, the FDA can issue
industry-wide advisory letters in an attempt to prevent businesses
from using certain ingredients in their products or
advertisements.6 8 As of November 2008, the FDA had issued five
62 Id.
63 Id.
' U.S. Food and Drug Administration, Dietary Supplements,
http://www.fda.gov/food/DietarySupplements/default.htm (June, 18 2009).
65 GAO, supra note 21, at 7.
66 Id. at 20.
67 Id.
68 Id.
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such advisory letters.6 9
b. FDA Shortcomings
Unfortunately, while the FDA employs a variety of
methods to protect consumers from dangerous supplements, its
efforts are not entirely sufficient. There are several significant
weaknesses in the FDA's surveillance and enforcement regime,
and the impact of these weaknesses is exacerbated. The agency
has been unable to effectively educate consumers about the risks
associated with the supplement industry.
One of the FDA's most glaring shortcomings is that the
agency is severely limited by a lack of information. 0 The FDA
lacks complete and accurate information concerning several
important facets of the dietary supplement industry. First, the
FDA is unlikely to be aware of all the dietary supplement
companies that exist within the United States. The Public
Health Security and Bioterrorism Preparedness and Response
Act of 2002 amended the Federal Food, Drug, and Cosmetic Act
to require dietary supplement manufacturers to register with the
FDA and identify themselves as dietary supplement firms. 72
However, some supplement companies may be exempt from
registration. For example, firms who manufacture products that
exclusively contain herbs, such as ginseng and echinacea, are not
required to register as dietary supplement firms under current
law.
Second, even if supplement companies register themselves,
the FDA could still lack vital information about them. Under the
Public Health Security and Bioterrorism Preparedness and
Response Act, supplement companies are only required to
provide their names and. addresses; they are not required to
provide detailed information about the products they sell, such as
their products' names and ingredients.4 Detailed product
information could help the FDA better analyze and respond to
adverse event reports concerning specific supplements and
69 In its advisory letters, the FDA advised marketers against using
products or advertisements containing aristolochic acid, comfrey,
androstenedione, Lipokinetix, and ephedra. Id.
70 Id. at 6.
" Id. at 22.
72 Id.
7 Id.
74 Id.
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ingredients."
Finally, the FDA does not have a complete database of
supplement-related side effects. Dietary supplement firms are
only required to report serious adverse events; they are not
required to report moderate or mild events.16 Consequently, the
FDA lacks a rich and vital source of information. The FDA could
use reports of mild and moderate side-effects in at least two
important ways. First, the reports could help the FDA identify
deleterious substances." Additionally, and perhaps more
importantly, the FDA could also use the reports to provide
evidence that a particular supplement poses a "significant or
unreasonable risk" to consumer health;" the burden on the FDA
to ban an ingredient is already extremely onerous, so the FDA
would benefit from any additional information concerning a
supplement's negative impact on consumers. The FDA's lack of
information limits its ability to both identify pernicious
substances and take action to prevent them from harming
consumers.
The FDA's enforcement and surveillance regimes also
have significant deficiencies. Most importantly, the FDA lacks
mandatory recall authority.7 9 Without mandatory recall
authority, the FDA must either attempt to institute a product
ban, pursue onerous and costly legal action, or plead with a
company to voluntarily issue a recall.s0 As previously discussed,
initiating a ban is not a very practical enforcement measure
because it is an incredibly onerous, expensive, and time-
consuming process. Similarly, initiating legal action against a
company, either by seeking criminal convictions or injunctions, is
relatively costly, time-consuming, and expensive as well. Legal
battles are also undesirable because consumers are left susceptible
to harmful supplements while the legal action takes places.
Therefore, in order to quickly protect consumers from deleterious
products, the FDA is often reduced to nudging companies to issue
voluntary recalls themselves.8"
Another limitation of the FDA's enforcement regime is
that most of its enforcement measures are reactionary. In order to
" Id.
76 Id. at 23.
" Id.
78 Id. at 17.
9 Id. at 6.
81 Id. at 20.
8' Id.
66 [Vol. 23:1
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institute a ban, take legal action, or encourage companies to
voluntarily issue a recall, the FDA has to first discover that a
supplement has caused harm to consumers. Since the FDA
commonly relies on consumer complaints to identify such
harmful products," it means that some consumers will be harmed
before the FDA can take action. The FDA's surveillance regime
is also tenuous. The FDA dedicates relatively few resources to
supplement oversight. The FDA dedicates about four percent of
the Center for Food Safety and Applied Nutrition's" resources to
supplement oversight, and the FDA dedicates only about one
percent of its total field resources to supplement oversight.8 4
Furthermore, inspection of dietary supplement facilities
represents less than one percent of FDA's total food
establishment inspections." Foreign inspections suffer far more
than domestic ones. Between 2002 and 2008, the FDA did not
conduct one foreign inspection of a dietary supplement firm.8 6
The FDA's rationale for devoting so few resources to supplement
oversight is that dietary supplements are generally considered to
be a lower risk than other causes of illness, such as foodborne
pathogens." Due to its weaknesses in enforcement and
surveillance power, the FDA has limited ability to identify and
protect the public from deleterious supplements.
Since the FDA's regulatory regime has several significant
shortcomings, it seems especially important for consumers to be
educated about the dietary supplement industry. However,
several studies have shown that consumers are not well informed.
A 2002 Harris Poll indicated that a majority of adults believe that
a government agency approves dietary supplements before they
reach the market.88 Another study conducted in 2003 by the
Department of Health and Human Services' Inspector General
indicated that dietary supplement labels do not present
information in a way that facilitates consumer understanding.89
These studies demonstrate that consumers do not seem to be
especially knowledgeable about the supplement industry, which
82 Id. at 23.
* The Center for Food Safety and Applied Nutrition is a division within
the FDA that is responsible for ensuring the safety of human food, including
dietary supplements. Id.
4 Id.
8s Id. at 24.
86 Id.
87 Id.
" Id. at 8.
89 Id.
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makes them especially vulnerable to pernicious supplements. The
FDA, however, has been largely unable to remedy the situation.
Another one of the FDA's shortcomings has been its
inability to effectively reach out to consumers and educate them
about dietary supplements.9 0 To the FDA's credit, it has taken
some initiative. In 2004, the FDA developed an educational
brochure that received approximately 171,000 website views and
had a distribution of over 40,000 paper copies. However, data
from the 2007 National Health Interview Survey indicated that
about 114 million individuals take dietary supplements.92
Therefore, the FDA's educational endeavors are reaching only a
small minority of supplement consumers.
Overall, the FDA employs a variety of effective
enforcement, surveillance, and prophylactic measures in its
mission to police the colossal and dynamic supplement industry.
However, the FDA's regime has significant limitations and lacks
the resources to sufficiently tackle the challenge. Fortunately,
another government organization, the FTC, is able to augment
the FDA's regulatory capabilities and help better protect
consumers.
2. Federal Trade Commission
Although the FDA has several shortcomings, the FTC
assumes substantial responsibility in policing dietary
supplements. The FTC has broad authority to regulate false,
misleading, and unsubstantiated claims, and the agency
proactively seeks out unscrupulous supplement companies. The
FTC plays a vital role in protecting consumers' health and
pocket books from deleterious and ineffective dietary
supplements.
a. FTC Regulatory Policies
The FTC has clear and robust policies regarding dietary
supplement advertising. In 1998, the FTC released a business
guide to describe its policies concerning dietary supplement
advertising.93 The guide is written in plain-English and includes
numerous examples to illustrate key ideas, thus serving as a very
90 Id.
9' Id. at 7-8.
92 Id. at 8.
" FTC Business Guide, supra note 17.
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practical and helpful tool to both potential supplement companies
and consumers.94 The FTC organizes its policies into three main
areas: identifying claims, substantiating claims, and a section
dedicated to a variety of miscellaneous claims, including
testimonials and expert opinions.
Identifying Claims. The FTC holds advertisers
accountable for both the implicit and explicit claims made in
their advertisements. 95 For example, if an advertiser claims that
"university studies have proved" an outcome, then the advertiser
is responsible for both its explicit claim, that multiple universities
have indeed come to that result, and also for its implicit claim,
that the universities' methods were sound."6 Furthermore, the
advertisement is considered as a whole." When an advertisement
lends itself to more than one reasonable interpretation, the
advertiser is responsible for substantiating all reasonable
interpretations. 98 For example, suppose a product claims that it
will boost the immune system and help maintain a healthy nose
and throat during the flu season. The product is called "Cold
Away" and the commercial advertisements include images of
people sneezing and coughing. The advertiser will be responsible
for substantiating that the product will help prevent all
symptoms of colds, not simply a healthy nose and throat, because
the advertisement and product name imply that the product can
be used to prevent colds."
Furthermore, even a truthful claim may ultimately be
misleading. If an advertiser omits material information, when
considered in light of how a consumer would reasonably interpret
the claim, then the advertisement can-be considered deceptive.o10
For example, say that an advertiser claims its herbal supplement
can relieve pain "without the side effects of over-the-counter pain
relievers." The herbal supplement manufacturer, however, knows
that its supplement has negative side effects, but the side effects
merely differ from those of over-the-counter pain relievers. The
advertiser would most likely be required to include a disclaimer
94 Id.
" Federal Trade Commission, Dietary Supplements: An Advertising Guide
for Industry, 3, http://www.ftc.gov/bcp/edu/pubs/business/adv/bus09.pdf (last
modified Apr. 2001) [hereinafter FTC Advertising Guide].
6 Id. at 4.
9' Id. at 3.
98 Id. at 3-4.
9 Id. at 4-5.
'" Id. at 5.
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or qualifying statement concerning the known side-effects in
order to establish that its advertisement was accurate and
veracious.10' The advertiser's disclosure statement must be clearly
and prominently displayed in the advertisement as well. A
statement that is displayed in fine print at the bottom of an
advertisement, is buried in a body of text, or located on a website
in an easily missed location may not be sufficient. 102
Substantiating Claims. The advertiser is responsible for
substantiating all of the explicit and implicit claims in its
advertisement.' The advertiser must have a reasonable basis for
all of its claims before the product is marketed to the public.104
Determining whether a specific claim is substantiated is tricky
and very difficult to regulate with bright-line rules, since
advertisements can present almost an infinite number of claims
that may or may not be deemed misleading in different situations.
The FTC has recognized the need to form a policy that is
adaptable to numerous types of claims and advertisements on the
market. Therefore, as opposed to crafting bright-line rules in an
attempt to address every type of advertising claim, the FTC
crafted a flexible set of guidelines that inform companies what is
expected of their advertisements.
According to the guidelines, "[t]he FTC's standard for
evaluating substantiation is sufficiently flexible to ensure that
consumers have access to information about emerging areas of
science. At the same time, it is sufficiently rigorous to ensure that
consumers have confidence in the accuracy of information
presented in advertising.""s
Whether a specific claim is misleading is determined on a
case-by-case basis.0 6 The FTC considers a number of factors
when assessing a claim's validity. Special emphasis is placed on
certain factors such as the type of product, the type of claim, and
the amount of substantiation that experts in the field believe to be
reasonable.1o' In general, products that relate to consumer health
and safety require a greater level of substantiation. 08 Similarly,
the repercussions of a false claim are taken into account. If a
1os Id. at 6.
1o2 Id. at 6-7.
103 Id. at 8.
104 Id.
10s Id.
106 Id.
1o7 Id. at 8-9.
1o8 Id. at 8.
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misleading claim would cause consumers to waste money or be
exposed to possible injury, the claim is more heavily
scrutinized.' Claims that would be difficult for consumers to
assess or verify on their own are held to a more exacting standard
as well."'o
When determining a claim's validity, the FTC affords
great weight to the amount of substantiation that would typically
be considered sufficient by experts in the field. Companies must
support their claims with "competent and reliable scientific
evidence," which is defined in the FTC's business guide as "tests,
analyses, research, studies, or other evidence based on the
expertise of professionals in the relevant area, that have been
conducted and evaluated in an objective manner by persons
qualified to do so, using procedures generally accepted in the
profession to yield accurate and reliable results."' Although the
definition seeks to create an unbiased uniform rule, several of the
factors within the definition can still be considered subjective.
For example, how can one determine whether or not a given
supplement company's research procedures were "generally
accepted in the profession" or if an advertiser's expert testimony
was from a professional whose expertise was in the "relevant
area"? In order to more precisely analyze each claim and develop
a clear and consistent regulatory policy, the FTC has further
detailed the factors that it will consider in order to determine if a
particular claim is sufficiently supported by scientific evidence.
The most basic requirement provides that a company
making a specific scientific claim must be able to demonstrate
that such claim is substantiated.11 2 For example, if the advertiser
claims that its product has been studied by U.S. and foreign
governments for many years, the company would be responsible
for showing that the product has indeed been studied by U.S. and
foreign governments."' The company would also be responsible
for demonstrating that a substantial body of research on the
supplement exists, since the claim implied that such research was
conducted.1 14 Other types of scientific claims, however, are more
nebulous and difficult to prove false.
While an advertisement might not outright lie, it might
' Id. at 9.
1o Id. at 8.
n1 Id. at 9..
112 Id.
".. Id. at 10.
114 Id.
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stretch the truth of a scientific study or present the evidence in a
misleading fashion. For example, suppose a company wants to
claim that its vitamin supplement "U Run" provides longer
lasting energy than other brands. To support its claim, the
company cites studies finding that lab rats injected with U Run's
active ingredients did indeed perform better on endurance tests
than control rats. However, the company neglects to mention that
U Run contains ingredients that rats are better able to synthesize
than humans. Additionally, the company fails to mention that
the rats were injected with a higher concentration of U Run's
active ingredient than is contained in the U Run tablet for human
consumption. In such a case, the FTC will assess the totality of
the circumstances to determine if the claim is supported.
Specifically, the FTC will assess: 1) the amount and type of the
evidence, such as the types of studies that were performed (e.g.,
human testing as opposed to in vitro studies); 2) the quality of the
evidence, such as examining how well the study was controlled
and the nature of the written reports; 3) the totality of the
evidence, such as by ensuring that an advertiser has not unduly
referenced one favorable study but discounted ten unfavorable
studies; and 4) the relevance of the evidence to the specific
claim."'
The relevance issue has proven to be an especially hot
topic in academia and in court decisions. Specifically, a salient
issue has been whether, and to what degree, advertisers can make
claims about the supplement as a whole by relying on scientific
studies that focus on one particular ingredient."' For example,
suppose a manufacturer has created an energy bar that contains
ingredients X, Y, and Z. Scientific studies of X have shown it to
be a safe and effective way to promote muscle growth. However,
a study has never analyzed the effects of X, Y, and Z taken
together. Can the supplement manufacturer claim that its
product is a safe and effective muscle growth supplement? While
it depends on the circumstances, courts have typically said no."
If a study is based on one particular ingredient, then the
advertiser's claim must specifically credit the ingredient for the
"I Id. at 10-16.
116 John E. Villafranco & Katie Bond, Dietary Supplement Labeling and
Advertising Claims: Are Clinical Studies on the Full Product Required? 64
FOOD & DRUG L.J. 43 (2009).
"' E.g., Park v. Cytodyne Technologies, No. GIC 768364, 2003 WL
21283814, at *13 (Cal. Superior May 30, 2003); FTC v. Nat'l Urological
Group, 645 F. Supp. 2d 1167, 1196 (N.D. Ga. 2008).
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results. In most cases, a claim cannot imply that an entire
supplement has been tested if only one of the key ingredients has
been tested alone."' The courts and the FTC have good reason
for promulgating such a policy. While an ingredient may be safe
when taken alone, the possible interaction effects it may have
with other ingredients are unknown and potentially deleterious.
Furthermore, consumers might falsely believe that a specific,
more expensive product is superior when in reality it is simply a
specific ingredient in the product, which may be ubiquitous in
many cheaper supplements as well, that is responsible for the
effect.
Finally, the FTC understands the difficulty and expense of
gathering scientific data to support one's supplement claims.119
The agency understands that if elaborate studies were required
for each new product, companies simply would not have an
incentive to produce many types of supplements, and therefore,
the public would not have access to a wide range of potentially
beneficial products. Accordingly, the FTC allows companies to
advertise their products without conducting extensive scientific
research. However, the FTC does require that the supplement
advertisers are candid with their claims. While the courts and the
FTC allow and even encourage advertisers to rely on scientific
studies of individual ingredients when advertising, the claims
must be identified for what they are: key ingredient claims. That
way, consumers remain fully and accurately informed of the
product.
Miscellaneous Claims. In addition to outlining general
policies for identifying and substantiating claims, the FTC also
devotes a section of its business guide to several specific
advertising techniques. In particular, the FTC focuses on
consumer and expert testimonials, claims based on traditional
use, and the use of the DSHEA disclaimer in advertising.
Perhaps the most important part of the miscellaneous
claims section is the portion dedicated to consumer and expert
testimony. According to the FTC, it is not enough that a
consumer testifier honestly believes his statement.12 0 Rather, the
statement's underlying claim must be supportable by scientific
evidence.12 ' Furthermore, a consumer's testimony must
demonstrate the typical results that can be expected from using
11s Park, 2003 WL 21283814, at *13.
11 FTC Advertising Guide, supra note 95, at 9.
120 Id. at 18.
121 Id.
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the supplement, not simply the most optimal results. 12 2 A
conspicuous disclaimer must accompany the testimony if it does
not represent average results. 123 In regard to expert testimony, an
expert testifier must have appropriate qualifications and must
have evaluated the product using appropriate scientific
methods. 2 4 The advertisement must also disclose any material
connection between the expert and the advertiser that may bias
the expert's testimony.125
Occasionally advertisers assert that their supplements
have been used in the past by many different groups of people.
These claims are referred to as traditional or historical use claims.
The FTC generally permits traditional use claims, however,
advertisers must be sure that their advertisements clearly state
that the only substantiation for their claims is traditional use and
not. scientific evidence.126 The advertiser must also ensure that it
can document the nature of the supplement's historical use.12 7
Furthermore, the DSHEA requires that all dietary
supplement labels be accompanied by a two-part disclaimer
stating that all claims regarding nutritional support have not
been evaluated by the FDA and that the product is "not intended
to diagnose, treat, cure or prevent any disease."128 While this
disclaimer is only required to be on supplement labels and not on
advertisements, there are times when the disclaimer could be
necessary, or at least helpful, in advertisements as well.129 For
example, if an advertisement portrays a supplement that
resembles a drug and the advertisement seems to suggest that the
supplement has been evaluated by the 'FDA, then the DSHEA
disclaimer might be necessary in order to ensure that the
advertisement is not misleading. 0
Overall, the FTC's policy regarding advertising claims
can be boiled down to one key principle: companies must make a
good faith effort to create an advertisement that fairly and
122 Id.
123 Id. at 18-19.
124 Id. at 19.
12S Id.
"6 If a historical use claim poses a significant threat if misleading-for
example, if the supplement claimed to cure cancer-then the FTC requires the
claim be substantiated with scientific evidence as well. Historical use will be
insufficient to substantiate the claim. Id. at 20.
127 Id. at 21.
121 Id. at 23.
129 Id.
130 Id.
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accurately reflects the totality of information and scientific data
available about 4 supplement.
The FTC has created a fantastic policy regarding
supplement advertising. The policy is clear, easy to understand,
and flexible enough to allow companies to make compelling
claims about all types of supplements. Moreover, the policy is
also sufficiently robust so as to outlaw misleading claims and
protect consumers. Advertisers constructing claims in good faith
can easily use these guidelines to help them create honest yet
compelling claims. However, simply crafting an effective
regulatory framework is insufficient to detect and prevent false
and misleading claims from swindling innocent consumers.
Accordingly, the FTC also needs a robust enforcement regime.
b. FTC Enforcement Power
The FTC uses several methods to enforce its policies
against unscrupulous supplement advertisers. 13 1 Its methods
include bringing settlements and cases against advertisers, and
also patrolling the Internet with a cadre of local, state, and
federal officials.132 - Altogether, the FTC's methods pose a
significant and powerful threat to false advertisers, but
unfortunately the FTC cannot target enough different offenders
to significantly deter unscrupulous marketing behavior.13
Cases and Settlements. Perhaps the FTC's strongest and
most widely used enforcement technique is taking legal action
against false advertisers. The FTC is constantly seeking out false
advertisements and bringing civil suits against the perpetrators.134
Sometimes the cases go all the way through trial, but typically the
cases will result in a settlement. 3 s While the FTC has been as
m3 Issues Relating to Ephedra-Containing Dietary Supplements: Hearing
Before the Subcomm. on Oversight and Investigations of the H. Comm. on
Energy and Commerce, 108th Cong (2003) (statement of J. Howard Beales, III,
Director, Bureau of Consumer Protection), available at
http://www.ftc.gov/os/2003/07/ephedratest.htm [hereinafter Issues Relating to
Ephedra].
132 Id.; Press Release, Federal Trade Commission, Surf Days: Detection
and Deterrence, http://www.ftc.gov/reports/fraud97/surfdays.htm (November
1997) [hereinafter Surf Days].
133 Id.; Dan Hurley, Revisiting a Poison Control Database on Supplement
Risks, N.Y. TIMEs, Feb. 6, 2007, at 1, available at
http://www.nytimes.com/2007/02/06/science/06dietcxn.html
134 Issues Relating to Ephedra, supra note 131.
13s John B. Reiss, Nichole Alling, Stephen Chuk, & Kristen Hall, Your
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diligent as ever in policing supplement claims, bringing legal
action is significantly costly and time consuming, so the agency
only brings a relatively small number of claims against the most
egregious advertisers.13 6 On average, from 1993 to 2003, the
agency filed less than ten lawsuits per year.' However, when the
FTC does initiate legal action, it is typically very successful.
In August 2008, the FTC settled charges with Airborne
Health, Inc., the maker of the popular Airborne cold prevention
tablets, for deceptive advertising claims. 13 Airborne purported to
have many clinically proven health benefits, but the FTC alleged
that Airborne had no credible evidence to support any of its
claims.' 3 Altogether, Airborne agreed to pay over $30 million in
consumer refunds and attorneys' fees.'4 0 In a similar lawsuit, the
FTC brought a class-action suit against Walgreens because of its
product Wal-Born. Wal-Born was an Airborne generic that also
claimed it could fight colds. Walgreens settled the case for $1.4
million.141
In another recent episode, the FTC's case for false
advertising against Xenadrine EFX ended in April 2009.142 The
marketers of Xenadrine EFX claimed that it was clinically
proven to cause rapid and substantial weight loss.143 Previously,
the court had ordered the individual defendants and their
company, RTC Research and Development, LLC, to pay $8
million in consumer redress for making false weight loss claims.144
The final order forbade all three defendants from making
misleading advertising claims in the future. 145
The FTC has brought several other actions against dietary
supplement companies that have also resulted in large
settlements. A federal district court ruled on summary judgment
that infomercials for Coral Calcium and Supreme Greens were
Business in Court: 2008-2009, 64 FOOD & DRUG L. J. 755, 768 (2009).
136 Issues Relating to Ephedra, supra note 131.
137 Id.
138 Reiss ET AL., supra note 135 at 775.
13 Id.
140 Id.
141 Id.
142 Press Release, Federal Trade Commission, FTC Concludes Case
Against Marketers of Xenadrine EFX; Court Ruling Requires Final Defendant
to Accept Settlement Terms, http://ftc.gov/opa/2009/04/xenadrine.shtm (April
24, 2009) [hereinafter FTC Concludes Case].
143 Id.
144 Id.
145 Id.
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misleading and violated the FTC Act.146 A Coral Calcium
infomercial claimed that the supplement could treat cancer,
Parkinson's, and heart disease and Supreme Greens claimed to be
a weight loss supplement. 147 The defendants were not able to
present scientific evidence to substantiate any of their claims, so
the court granted FTC's motion for $54 million in consumer
redress to cover the full amount of consumer product sales. 148
In another case, National Urological Group and several
other defendants were ordered to pay $15 million for making
deceptive claims in their dietary supplement advertisements. 149
The defendants claimed that their products Thermalean and
Liproden were clinically proven to cause weight loss, and that
their product Spontane-ES could treat ninety percent of men with
erectile dysfunction.150 The court held that the defendants had not
presented "competent and reliable scientific evidence" to support
their claims.s15
In yet another development, the FTC recently brought
charges against Kevin Trudeau, a longtime marketer of dietary
supplements and other products.15'Over the years, Trudeau
claimed that his various products could cure cancer, AIDS, severe
pain, hair loss, slow reading, poor memory, debt, and obesity.s15
The FTC brought false advertising claims against Trudeau
multiple times, particularly focusing on the claims that he made
in infomercials.154 In the most recent case, a federal district court
sided with the FTC in concluding that Trudeau had
misrepresented a book and thereby violated previous sanctions
against him.15 The court found Trudeau in contempt and ordered
him to pay $37.6 million in redress and banned him from
appearing in any infomercials for the next three years.156
The FTC continues to bring lawsuits against
unscrupulous advertisers. The lawsuits are typically successful at
obtaining large monetary judgments and sometimes sanctions
146 Reiss ET AL., supra note 135 at 775.
147 Id.
148 Id.
149 Id. at 775.
"s Id. at 776.
151 Id.
152 F.T.C. v. Trudeau, 579 F.3d 754, 756 (7th Cir. 2009).
153 Id.
154 Id.
155 Id.
156 Id. at 779. The Seventh Circuit affirmed that Trudeau was in contempt
but remanded for redetermination of sanctions.
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against the defendants. However, bringing a lawsuit is an
onerous and difficult task that requires significant time and
resources. The FTC simply does not have enough resources to
bring lawsuits against many supplement companies. Therefore,
the FTC necessarily relies on other methods of regulating dietary
supplement advertisers.
Internet Regulation. The Internet poses an especially.
difficult regulatory challenge for the FTC. It is becoming
increasingly easier for an individual to set up a website and
market a dietary supplement because the online process can be
completed relatively quickly and requires little effort."' Indeed, a
quick Google search shows that the number of dietary
supplement advertisements on the web is staggering. In response
to the proliferation of Internet solicitors, the FTC has been
innovative in developing ways to regulate this industry. One such
response has been the development of "surf days." In the late
1990's, the FTC worked with the FDA to organize a cadre of
federal, state, and local officials to surf the Internet and look for
potential violations.' The FTC identified types of deceptive
practices that appeared to be common on the Internet and
developed a protocol to find sites that displayed the undesired
practices. 15 9 At a particular date and time, federal, state, and local
officials searched the web for the undesired websites and then
sent their findings to FTC officials.16 0 FTC attorneys then
identified which of those sites were most likely breaking the law
and sent email messages to the sites' proprietors informing them
that their advertisements were in violation of FTC policy and
that they may be subject to enforcement action.16 1
Through its surf day efforts the FTC has been able to help
police both domestic and international supplement companies. In
January and February 2002, the FTC worked with the FDA, the
Australian Competition and Consumer Commission, and
nineteen other members of the International Marketing
Supervision Network to surf the internet for online marketing of
" THOMAS L. FRIEDMAN, THE WORLD is FLAT 88 (2006).
1 Robert G. Pinco & Todd H. Halpern, Guidelines for the Promotion of
Dietary Supplements: Examining Government Regulation Five Years After
Enactment of the Dietary Supplement Health and Education Act of 1994, 54
FOOD & DRUG L.J. 567, 583 (1999).
159 Id.
160 Id.
161 Id.
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health-related products. 16 2 As a result, the FTC sent over 280
advisory letters to domestic and foreign sites that were identified
as making questionable claims for health-related products or
services including dietary supplements.1 63
While surf days demonstrate the FTC's ingenuity and
willingness to find new strategies to police the supplement
industry, the efficacy of surf days is relatively unclear. Estimates
of compliance with surf-day recommendations vary greatly. FTC
investigators and attorneys made follow-up visits to websites
issued surf day warnings approximately one month later and
found that between "18 to 70 percent of the questionable sites had
been eliminated or revised."164 While surf days are clearly having
some impact, the extent to which the warnings really deter
unscrupulous behavior is still unclear.
In addition to targeting unscrupulous online supplement
advertisers, the FTC has tried to protect consumers by
identifying and reaching out to particularly unwary consumers.
In order to do so, the FTC developed several "teaser" websites
that were made to resemble supplement websites that commonly
contain misleading claims. 161 When the potential consumer would
click on a link to buy the product or service, he or she would be
taken to a page that included a warning, advice on how to avoid
being defrauded, and a hyper-text link to the FTC website.'66 By
targeting unscrupulous online advertisers and attempting to
educate unwary consumers, the FTC has developed an
innovative, two-pronged approached to combating false
supplement advertising on the Internet.
By bringing legal claims, the FTC is able to take powerful
and effective enforcement action against a limited number of
sinister advertisers, and through its online efforts, the FTC has a
broad reach to police both international and domestic marketers.
However, the agency must improve. The FTC's most glaring
deficiency is that it lacks the resources to diligently police and
enforce its policies against many of the potentially
162 Dietary Supplements and Their Use for Weight-loss Purposes: Hearing
Before the Subcomm. on Oversight of Government Management, Restructuring,
and the District of Columbia of the S. Comm. on Governmental Affairs, 107th
Cong. (2002) (statement of Joseph A. Levitt, Director, Center for Food Safety
and Applied Nutrition), available at
http://www.fda.gov/NewsEvents/Testimony/ucm115169.htm.
163 Id.
164 Surf Days, supra note 132.
16s Pinco & Halpern, supra note 158, at 583-84.
166 Id.
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unconscionable supplement companies who market their
products to the public. While the FTC has attempted to police the
supplement industry, it simply does not have enough resources to
do a thorough job.167 Therefore, with its current shortcomings, the
FTC is insufficient to protect consumers from false and
misleading advertising.
B. Private Sector Regulation
In addition to government regulation from the FDA and
FTC, dietary supplements are also policed by the private
industry. Local Better Business Bureaus and the NAD regularly
seek out and take action against sinister dietary supplement
companies. These self-regulatory agencies palpably augment
consumer protection against deleterious supplements and false
advertisements.
1. Council of Better Business Bureaus
One of the most well-known and powerful private
agencies in place to protect consumers is the Council of Better
Business Bureaus ("CBBB"). The CBBB is a non-profit
organization that is "dedicated to fostering honest and responsive
relationships between businesses and consumers, instilling
consumer confidence and contributing to a trustworthy
marketplace for all." 68
The CBBB is a private, non-profit organization that is
composed of both corporate partners and independent, local
Better Business Bureaus ("BBBs").169 The CBBB has a mutually
supportive relationship with both its corporate partners and its
constituent local BBBs in the United States and Canada.o The
CBBB's corporate partners consist of approximately 200
organizations that are leaders in their respective industries and
"share a commitment to corporate responsibility and the ideals of
16' Berin Szoka, How Financial Overhaul Could Put the FTC on Steroids
& Transform Internet Regulation Overnight, 6 THE TECHNOLOGY &
LIBERATION FRONT 7, 2 (2010), available at,
http://techliberation.com/2010/03/17/how-financial-overhaul-could-put-the-ftc-
on-steroids-transform-internet-regulation-overnight/.
168 Council of Better Business Bureaus, BBB Structure,
http://www.bbb.org/us/cbbb (last visited Sept. 21, 2010) [hereinafter BBB
Structure].
169 Id.
170 Id.
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the BBB.""' The corporate partners are typically fairly large
companies (e.g., .Verizon Wireless and Nestle USA are both
corporate partners). 7 2 The CBBB is also composed of 122
independent local BBBs across North America that serve both
businesses and consumers in their local communities."' Local
agencies govern their own regions and process all complaints.17 4
Businesses may or may not choose to become members of
their local BBB.'7" In order to become accredited (membership is
synonymous with accreditation'7 6 ), business are required to go
through a lengthy review process, agree to abide by certain
ethical standards,"' and pay an annual fee.7  Depending on the
size of the company, accreditation can cost anywhere from
several hundred dollars to several thousand dollars a year.17 9 The
majority of the BBB's funds come from these accreditation
fees.so Once accredited, a company is permitted to use the BBB's
seal in its advertising materials.'
The BBB protects the marketplace in a variety of ways.
Perhaps the most well-known and effective method is through the
processing of complaints. Local BBBs accept complaints about
business from both consumers and other businesses. 82
Complaints can be filed against both accredited and non-
accredited businesses."' The process for filing a complaint is
171 Id.
172 Council of Better Business Bureaus, Roster of Corporate Partners,
http://www.bbb.org/us/corporate-partners/roster (last visited Sept. 21, 2010).
'a BBB Structure, supra note 168.
'74 Council of Better Business Bureaus, BBB Online Complaint System,
https://odr.bbb.org/odrweb/public/getstarted.aspx (last visited Sept. 21, 2010)
[hereinafter BBB Online Complaint System].
" Council of Better Business Bureaus, About BBB Accreditation,
http://www.bbb.org/us/bbb-accreditation-application (last visited Sept. 21,
2010) [hereinafter About BBB Accreditation].
"6 Council of Better Business Bureaus, Frequently Asked Questions,
http://www.bbb.org/us/bbb-faqs/#Does%20BBB%20Accreditation (last visited
Sept. 21, 2010).
177 Id.
178 David Lazarus, Better Business Bureau Grades Companies on a
Peculiar Curve, Los ANGELES TIMES, Jan. 21, 2009, at 1, available at,
http://articles.latimes.com/2009/jan/21/business/fi-lazarus21 (last visited Sept.
21, 2010).
179 Id.
180 Id.
181 About BBB Accreditation, supra note 175.
182 BBB Online Complaint System, supra note 174.
183 Id.
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relatively simple and can be done by completing an online form
on the BBB's website.' 8 4 Once filed, the local BBB forwards the
complaint to the respective company within two business days.' 5
The company is then asked to respond to the complaint within
fourteen business days and the customer is notified of the
business' response once it is received by the local BBB.186 Before
filing a complaint with the BBB, customers are strongly
encouraged to attempt to resolve the dispute with the company
itself.'In some cases, the local BBB may even offer arbitration
or mediation to assist in resolving the conflict.1'
In addition to handling complaints, the BBB also helps
encourage responsible business behavior by publishing a letter-
grade rating system of businesses.'89 Any business may receive
ratings, regardless of whether or not it is accredited by the
BBB.'9" The letter grade system rates companies on a scale of A+
through .F (a much more precise system than the previous
"satisfactory" or "unsatisfactory" rating system that was
employed by the BBB).m'i
The BBB considers a number of factors when rating a
company.'92 One of the most significant considerations involves
complaints. The BBB considers how many complaints have been
filed against a business, the severity of the complaints, and the
business' response to the complaints, including how quickly the
business responded and the efficacy of the response."'3 The BBB
also takes into account the business' length of time in operation,
whether or not the business has honored past commitments to
mediate and comply with mediation obligations, and the
existence of any known government actions against the company
that are related to marketplace activities. 194
The BBB also considers whether or not a business is
184 Id.
185 Id.
186 Id.
187 Id.
18 Id.
18 Council of Better Business Bureaus, What Are BBB Ratings?,
http://www.bbb.org/business-reviews/ratings/index.html (last visited Sept. 21,
2010) [hereinafter What Are BBB Ratings].
190 Lazarus, supra note 178, at 1.
191 Id.
192 What Are BBB Ratings, supra note 180.
193 Id.
194 Id.
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accredited when determining the business's rating.'95 A business
receives four points, out of a possible ninety, if it is accredited by
the BBB." 6 This preferential treatment of accredited businesses
has been questioned and criticized as being "pay-for-play." 9 7
Since companies have to pay to become accredited, opponents of
the rating system contend that business can simply pay extra
money to receive a better ranking.'9 8 Regardless of the business'
rating, however, consumers are free to read descriptions of why
the company was given a particular grade.199 Accordingly, a less-
than-perfect letter grade might not discourage consumers from
doing business with a particular organization. For example, a
company's low grade might have been awarded because
"complaints [were] unresolved, meaning that the company failed
to properly address the complaint allegations or their response
was inadequate."2 00 Conversely, a positive rating might not
guarantee business if particularly dubious comments are included
in the company's grade report. The BBB's letter-grade system
and accompanying descriptions enable consumers to make more
fully informed decisions about whether or not they feel
comfortable and confident interacting with a particular business
organization. Finally, the BBB also promotes honest business
practices by distributing consumer and business education tips
and by posting local marketplace alerts on its website.2 0 '
2. National Advertising Division
a. NAD Purview, Policy and Structure
The National Advertising Division ("NAD") is the
investigative division of the CBBB.2 02 The NAD is charged with
1' Council of Better Business Bureaus, BBB Ratings Overview,
http://www.bbb.org/business-reviews/ratings/overview.html (last visited Sept.
21, 2010) [hereinafter BBB Ratings Overview].
196 Id.
19 Lazarus, supra note 178, at 3.
9 Id.
199 Id.
200 Id.
20' BBB Structure, supra note 168; Council of Better Business Bureaus,
BBB Alerts Consumers: Watch out For Unscrupulous Online Payday Lenders,
http://austin.bbb.org/article/bbb-alerts-consumers-watch-out-for-
unscrupulous-online-payday-lenders-17902 (Mar. 3, 2010).
202 Council of Better Business Bureaus, NAD Case Reports,
http://www.bbb.org/us/National-Advertising-Division/Reports/ (last visited
Sept. 21, 2010) [hereinafter NAD Case Reports].
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monitoring and evaluating truth and accuracy in national
advertisements directed towards consumers age twelve and
over.203 To be deemed national, the advertisement must be
disseminated nationwide or on a broad regional basis.20
Complaints concerning local advertisements are handled by the
local BBB.2 0s
The NAD's policies are set by the National Advertising
Review Counsel ("NARC"). NARC is another independent, non-
profit organization whose mission is to "foster truth and accuracy
in national advertising through voluntary self-regulation." 2 06
NARC provides guidance and sets advertising standards for the
NAD as well as a number of other self-regulatory agencies.207 In
addition to having carefully constructed policies, the NAD also
boasts top-notch legal talent to process claims and handle
disputes. The NAD's staff includes four attorneys, two senior and
two staff, who have experience with claims substantiation,
advertising and trade regulation, and litigation and arbitration.2 08
The NAD plans to augment its staff with another attorney whose
sole focus will be dietary supplement regulation.2 09
The NAD recently partnered with the Council for
Responsible Nutrition in order to help -regulate dietary
supplements. The Council for Responsible Nutrition agreed to
provide the NAD with nearly $500,000 over three years in order
to allow the NAD to increase the number of dietary supplement
cases it handles. 2 10 The money will be provided to the NAD with
no strings attached2 11 and the agency will most likely use the
203 Id.
204 Council* of Better Business Bureaus, About NAD,
http://www.bbb.org/us/About-National-Advertising-Division (last visited Sept.
21, 2010) [hereinafter About NAD].
205 Id.
206 Council of Better Business Bureaus, Advertising Review Services,
http://www.bbb.org/us/Advertising-Review-Services/ (last visited Sept. 21,
2010).
. 207 The NARC also sets standards for the Children's Advertising Review
Unit (CARU), the National Advertising Review Board ("NARB") and the
Electronic Retailing Self-Regulation Program ("ERSP"). Id.
208 Council of Better Business Bureaus, Contact Information,
http://www.bbb.org/us/national-advertising-division-contact/ (last visited Sept.
21, 2010); National Advertising Division, How NAD Works,
http://www.nadreview.org/AboutNAD.aspx (last visited Sept. 21, 2010)
[hereinafter How NAD Works].
2 Villafranco & Lustigman, supra note 18, at 710.
210 New Industry Initiative, supra note 2.
211 Id.
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funds in order to hire an additional attorney to focus exclusively
on the dietary supplement industry.212
The NAD's primary function is to review disputes
between national advertisers and provide a low cost alternative
to litigation.213 In order to settle claims, the NAD boasts a "unique
hybrid form of dispute resolution" that involves "working closely
with in-house counsel, marketing executives, research and
development departments, and outside consultants to decide
whether claims have been substantiated."214 The NAD strives to
make the dispute resolution process as efficient, quick, and fair to
all parties as possible. The dispute resolution process commences
when a party files a complaint. Other businesses, local BBBs,
individual consumers, consumer groups, and even the NAD itself
can file complaints.2 15 To file a complaint, the challenging
company must pay a filing fee, which is contingent on the
company's gross annual revenue and whether or not the company
is a CBBB corporate partner.2 16 CBBB corporate partners pay
$2,500 per complaint and non-CBBB corporate partners pay
between $6,000 and $20,000 depending on the challenging
company's gross annual revenue.2 17 Consumers, however, do not
have to pay a filing fee in order to file a complaint. 218 Once a
complaint is received, the NAD will conduct an investigation and
provide a written response within sixty days.21 9 During the
investigation, the challenged company is typically allowed to
continue advertising.220 All information collected during the
proceedings remains private except for the NAD's decision, the
challenger's and the advertiser's positions, and a statement by
the advertiser.22 1
Compliance with the NAD's decision is completely
voluntary.2 22 The NAD's decision is not binding on the FTC or
on the businesses that are parties to the complaint.223 However, if
212 Villafranco & Lustigman, supra note 18, at 710.
213 How NAD Works, supra note 208.
214 About NAD, supra note 204.
2 NAD Case Reports, supra note 202.
216 How NAD Works, supra note 208.
217 About NAD, supra note 204.
218 Telephone interview with Sheryl Harris, National Advertising
Division, (Apr. 15, 2010).
219 About NAD, supra note 204.
220 Id.
221 Id.
222 How NAD Works, supra note 208.
223 Villafranco & Lustigman, supra note 18, at 709.
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an advertiser either refuses to cooperate with the NAD
proceedings or fails to comply with its decision, there may be
substantial negative consequences. Bad publicity might hurt a
business' reputation and hinder future sales. In addition, the
NAD can refer cases to the FTC, and the FTC tends to give
referred cases a high priority.22 4 In a statement to Congress, C.
Lee Peeler, President and CEO of the NARC, asserted that:
During the nearly 40 years of its existence, the
advertising self-regulatory system has received strong
support from the FTC. The FTC also has consistently
supported self-regulation by committing to give a
priority to examining referrals from the advertising self-
regulatory process. Referrals to the FTC of advertisers
that refused to participate in the self-regulatory process
have resulted in FTC lawsuits and significant monetary
penalties.22 5
Since the FTC firmly supports the NAD, supplement
companies have a strong incentive to comply with NAD's
recommendations. In his statement to Congress, Peeler estimated
that "well over 90% of participants 'voluntarily comply' with
NAD's decisions. "226 Overall, NAD's decisions are respected by
advertisers even though compliance is voluntary.
b. NAD Enforcement Action
The NAD provides a substantial boost to supplement
regulation. In particular, the NAD is fairly diligent in bringing
claims against unscrupulous companies. Between April 1, 2009
and April 8, 2010, a total of thirty-two complaints were brought
against dietary supplement companies.2 27 Of those complaints,
224 Id. at 710.
225 CBBB Statement to Congress on Advertising Trends and Consumer
Protection: Hearing Before the Subcomm. on Consumer Prot., Prod. Safety,
and Ins., 111th Cong. (2009) (statement of C. Lee Peeler, President and CEO,
National Advertising Review Council), available at
http://www.bbb.org/us/article/cbbb-statement-to-congress-on-advertising-
trends-and-consumer-protection-11635 [hereinafter CBBB Statement to
Congress].
226 Id.
227 National Advertising Division, Latest Cases,
http://www.nadreview.org/search/search.aspx?doctype= 1&casetype= 1 (last
visited Sept. 21, 2010).
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twenty-five were filed by the NAD itself.2 28 Six of the complaints
were filed by competitors and one complaint was filed by the
Council for Responsible Nutrition.2 29 Not one complaint was filed
by a consumer, despite the fact that consumers may file
complaints without paying filling fees.23 0 The numbers show that
in practice the NAD is still forced to identify and file the vast
majority of claims itself, even though it theoretically has the help
of thousands of concerned consumers and business on its side.
Although it alone assumes much of the responsibility for
identifying claims, the NAD still manages to pose a formidable
regulatory force in the supplement industry. In order to protect
consumers from misleading claims, the NAD frequently
recommends that advertisers substantially alter their
advertisements. In its recommendations, the NAD thoroughly
examines all aspects of a company's advertisement. For example,
on February 16, 2010, the NAD issued a press release
recommending that Artis Marketing discontinue several
advertising claims that it was using to market its weight-loss
supplement Slimforce 7.231 The NAD recommended that Artis
Marketing discontinue its claim that Slimforce 7 could "help to
reduce your hunger cravings" because there was no evidence
evaluating the product's ingredients' effects on hunger.23 2 The
NAD found that there was no evidence to support claims that
Slimforce 7, or its ingredients, continued to support weight loss
after a consumer had finished taking the supplement. 23 3 Finally,
among other determinations, the NAD recommended that the
company discontinue its testimonials and claims suggesting that
the product would result in weight loss regardless of diet and
exercise.23 Artis Marketing stated that it would "take NAD's
concerns into account in future advertising. "235
However, while the NAD wants to protect consumers, it
also understands the importance of fairness to businesses. The
228 Id.
229 Id.
230 Id.
231 Press Release, National Advertising Division, NAD Recommends Artis
Marketing Discontinue Wide Range of Claims for "Slimforce 7" Dietary
Supplement,
http://www.nadreview.org/docView.aspx?DocumentlD=7899&DocType=1Ne
ws (Feb. 16, 2010).
232 Id.
233 Id.
234 Id.
235 Id.
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NAD takes into account the difficulties of substantiating
compelling advertising claims for novel and complex dietary
supplements and consequently it does not recommend changes
for all of the advertising claim complaints it receives. For
example, on January 25, 2010, the NAD issued a press release
stating that Lifes2 Good Natural Healthcare could support certain
advertising claims for its dietary supplement, Viviscal, which was
marketed to prevent thinning hair.236 Lifes2Good had claimed
that "Viviscal strengthens and nourishes thinning hair from
within while promoting existing growth."23 7 The NAD found that
the claim was supported by studies conducted on both the
product Viviscal and on some of Viviscal's individual
ingredients. 238 The NAD also found support for Lifes2Good's
claim that Viviscal was "[r]ecommended by top celebrities and
models."m2  Finally, the NAD agreed that there was evidence to
support claims that the product was both safe and composed of
all natural ingredients.
The NAD did, however, suggest that Lifes2Good amend
its claim that "100% natural ingredients make Viviscal safe and
free of harmful side effects" in order to prevent the possibility of a
misleading interpretation that the product was safe because it
was made of all natural ingredients. 24 0 The NAD also
recommended that Lifes2Good discontinue its claim that
"Viviscal is doctor recommended" and suggested that the
company discontinue its before-and-after photo comparison.241
The Lifes2Good case presents a compelling example of how the
NAD provides effective consumer protection while still
remaining fair to dietary supplement marketers.
Through its efforts in bringing and resolving claims
against unscrupulous supplement manufacturers, the NAD
provides a significant boost to dietary supplement regulation.
While the NAD is not without its shortcomings, the agency still
plays a notable role in helping to protect consumers from false
236 National Advertising Division, NAD Finds Lifes2Good Can Support
Certain Advertising Claims for "Viviscal," Recommends Advertiser Modify
Certain Claims,
http://www.nadreview.org/docView.aspx?DocumentlD= 7869&DocType= 1
(Jan. 25, 2010).
237 Id.
238 Id.
239 Id
240 Id.
241 Id.
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and misleading supplement advertisements.
C. Joined Forces: The FTC and NAD as an Effective Unit
The NAD and the FTC essentially have a symbiotic
relationship. The NAD needs the FTC in order to compel
advertisers to comply with its recommendations and keep its
costs as low as possible. The NAD's presence helps save the FTC
valuable resources and also promotes greater compliance with the
FTC's regulatory policies. The NAD most likely would not be
able to succeed without the FTC. While the NAD boasts a ninety
percent compliance rate,2 42 it is the FTC's presence that compels
advertisers to voluntarily comply with the NAD's
recommendations. If the FTC did not exist, then companies
would most likely ignore the NAD altogether.
Metabolic Research provides a perfect example of the
NAD's dependency on the FTC.243 In 2009, the NAD
recommended that Metabolic Research discontinue certain claims
that it was making for its dietary supplement Stemulite.24 4
Metabolic Research ignored the complaint, so the NAD referred
the issue to the FTC, which subsequently contacted Metabolic
Research.2 45 Once the company heard from the FTC, it
voluntarily agreed to comply with the NAD's previous
recommendations.2 4 6 In 2010, the NAD again looked at several
new claims made by Metabolic Research and on March 3, 2010,
once again issued a press release recommending that the company
amend and omit some of it its claims.2 47 This time, Metabolic
Research stated that it had "every intention on being compliant in
all respects."2 48
While Metabolic Research initially ignored the NAD's
recommendations, it immediately changed its position when it
242 CBBB Statement to Congress, supra note 225.
243 Press Release, National Advertising Division, NAD Recommends
Metabolic Research Modify, Discontinue Claims for "Stemulite,"
http://www.nadreview.org/docView.aspx?DocumentlD=7925&DocType=1
(Mar. 3, 2010) [hereinafter NAD Recommends Metabolic Research].
244 Id.
245 Id.
246 Id.
247 In particular, the NAD found that the company had insufficient
evidence to support claims that Stemulite increased muscle gain, endurance,
wellness, and energy, and consequently the NAD recommended
discontinuance of all the claims. Id.
248 NAD Recommends Metabolic Research, supra note 243.
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was contacted by the FTC.24 9 The mere threat of engaging with
the FTC was enough for the company to cooperate with the
NAD's voluntary alternative dispute resolution process, and it
seems safe to assume that many other companies would behave
the same way. The FTC serves as a looming threat to advertisers
because it boasts the capability of imposing severe penalties and
future sanctions and, therefore, companies will keenly comply
with NAD procedures in order to avoid more serious
repercussions at the hands of the FTC
The NAD benefits from the FTC's presence in one other
notable way. Since the FTC bears the price of bringing large and
expensive lawsuits against some of the most egregious and costly
advertising offenders, it prevents the NAD from having to do the
same and, therefore, helps keep the NAD's costs relatively low.
The NAD can therefore afford to bring more cases against
unscrupulous supplement companies. Furthermore, by not
having to fund expensive lawsuits, the NAD can keep the
complaint filing fees as low as possible. The NAD currently
receives few annual complaints from competitive businesses and
consequently needs to do everything it can to encourage
participation. By keeping filing costs low, the NAD can help
boost business participation.
While the NAD relies on the FTC for success, the FTC
also prospers from the existence of the NAD. The NAD can
quickly and efficiently resolve cases that the FTC would have
otherwise handled. By resolving these cases, the NAD saves the
FTC valuable time and resources which the FTC can devote to
other pressing concerns. In addition, the NAD's vigilance makes
it more likely that supplement manufactures will be caught and
reprimanded for making false and misleading claims. The
increased likelihood of being caught compels advertisers to have
greater respect for, and be more likely to adhere to, the FTC's
policies and advertising guidelines. The FTC and the NAD both
benefit from one another and together the two agencies provide a
more robust regulatory force than either agency could provide
alone.
249 Id.
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III.Critique of the Current Dietary Supplement Regulatory
Regime
A. Criticisms of Current Dietary Supplement Regulation
There are several prominent criticisms of the United
States' current dietary supplement regulatory regime. The most
poignant and convincing argument is that many people are being
harmed by deleterious supplements every year. During the period
of 1983 to 2004, there were 230 deaths associated with dietary
supplements. 25 0 In 2005 alone, dietary supplements were
responsible for 5,334 adverse reactions, 17,843 health care visits,
and 12,314 medical outcomes.25 1 Perhaps even more chilling than
the sheer number of supplement-related incidents is the fact that
the numbers of incidents are rising. In 1994 there were only four
reported deaths caused by supplement use, whereas in 2005 there
was a record twenty-seven reported deaths.252 Granted, the
increased number of incidents could simply be due to the fact that
more people are reporting supplement-related incidents now than
in the past. Indeed, the number of reported supplement-related
adverse events has significantly increased in recent years due to
the introduction of mandatory reporting requirements.2 5 3
However, the notion that supplement-related incidents have
increased simply because individuals are more likely to report
them should not assuage concerns regarding the safety of .the
supplement industry. Underreporting of adverse events is still
rampant. The FDA estimated that only two percent of
supplement-related adverse events are reported.2 54 That means
that the actual number of supplement-related incidents is likely to
be much higher than the numbers suggest. Furthermore, the
supplement industry is rapidly expanding: 4,000 supplement
products were available to consumers in 1994 whereas 75,000
.supplement products were available to consumers in 2008.255
With such an influx of supplements hitting the market, it seems
250 Dan Hurley, Diet Supplements and Safety: Some Disquieting Data,
N.Y. TIMES, Jan. 16, 2007, at 1, available at
http://www.nytimes.com/2007/01/16/health/16diet.html?pagewanted=1&_r=1.
251 Dan Hurley, Revisiting a Poison Control Database on Supplement
Risks, N.Y. TIMES, Feb. 6, 2007, at 1, available at
http://www.nytimes.com/2007/02/06/science/06dietcxn.html
252 Hurley, supra, note 250, at 1.
253 GAO, supra note 21, at 5.
254 Id.
255 Id. at 1.
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quite likely the number of supplement-related incidents is indeed
rising. Therefore, the lurid statistics demonstrating the large
number of adverse supplement-related incidents should be a
significant cause for concern.
Critics of the current regulatory policy blame the deluge of
supplement-related incidents on the government's inability to
police the supplement industry. While critics offer several reasons
why government agencies are inadequate, one particularly strong
criticism is that government agencies are unable to effectively
enforce their policies against unscrupulous companies. 256 Bruce
Silverglade, the legal affairs director for the Center for Science in
the Public Interest, claimed that "[w]hen it comes to dietary
supplements, it's like the Wild West, and the bad guys know they
don't have to take the sheriff seriously.25 7 Even when confronted
with people dying from a dangerous substance like ephedra, the
FDA has limited authority to get the product off the market."25 8
Silverglade's claim is well-founded. Surf-day follow-up studies
estimated company compliance to be as low as eighteen
percent.2 59 Additionally, companies seem to be relatively
undaunted by the threat of FDA inspections. The FDA
conducted 804 inspections of dietary supplement facilities from
2002 to 2008 and investigators identified potential problems in
forty-nine percent of the facilities.260 Overall, companies can defy
government policies because it is exceedingly unlikely that they
will get caught and punished. While the FDA, the FTC, and the
NAD do successfully bring a fair number of cases every year
against supplement manufactures, the agencies simply do not
have enough resources to pursue legal action against a large
percentage of unscrupulous supplement companies. In a
congressional hearing, the FTC testified that nearly forty percent
of the weight loss claims that it sampled in 2001 made at least one
representation that was "almost certainly false." 26 1 In 2008 there
were 75,000 supplement products.2 62 Forty percent of 75,000
products means that there are potentially 30,000 misleading
256 Center for Science in the Public Interest, FDA Can't Protect Americans
from Dangerous Dietary Supplements, GAO Says,
http://www.cspinet.org/new/200903022.html (March 2, 2009).
257 Id.
258 Id.
259 Surf Days, supra note 132.
260 GAO, supra note 21, at 18.
261 Issues Relating to Ephedra, supra note 131.
262 GAO, supra note 21, at 1.
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products on the market. Even if all three U.S. agencies brought a
total of one hundred cases a year-a very generous estimate2 63 -
unscrupulous supplement companies would still only have a one
in three hundred chance of being legally pursued.
Even if a supplement company gets caught, typically the
worst case scenario for the company is that it loses all of its
profits and is sanctioned from creating false advertisements in the
future. 264 These punishments leave an offending company
essentially no worse off than it would have been before it
swindled consumers by illegally marketing supplements. Between
the relatively moderate penalties and extreme unlikelihood of
getting caught, many companies choose to roll the dice and
market their supplements with misleading claims.
Overall, critics' complaints of the current dietary
supplement regulatory regime are well founded. Deleterious
supplements are getting to market and regulatory agencies are
not able to sufficiently police all of the products and their
advertisements.
B. Corrective Measures: Relatively Inexpensive and Minimally-
Burdensome Methods of Enhancing the Regulatory Regime
While the FDA, the FTC and the NAD provide a strong
regulatory system, deleterious supplements and misleading claims
still harm consumers and changes in the regulatory system are
necessary. Understandably, the agencies do not have a surplus of
extra funds which they can use to boost their regulatory regimes.
However, this article advocates several methods by which the
FDA and FTC could significantly increase consumer protection
against both harmful supplements and misleading claims that
would be relatively inexpensive without being unduly
burdensome to implement.
Bolstered Reporting Requirements to Create a More
263 The NAD brought 32 cases from April 1, 2009 to April 8, 2010,
National Advertising Division, Latest Cases,
http://www.nadreview.org/search/search.aspx?doctype= 1&casetype= 1 (last
visited Sept. 21, 2010); The FTC brought an average of 9 cases per year from
1993 to 2003, Issues Relating to Ephedra, supra note 131. The FDA pursued
legal action against an average of about 6 companies per year from 2002
through 2008, GAO, supra note 21, at 20 (reporting that the FDA initiated legal
action for 27 seizures and 6 injunctions from fiscal year 2002 through July 18,
2008). Using those figures, the agencies bring a total of approximately 47 cases
per year.
264 FTC Concludes Case, supra note 142.
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Comprehensive Database. First and foremost, the FDA needs to
gather a complete set of data regarding the dietary supplement
industry in the United States. The FDA cannot hope to
effectively combat pernicious dietary supplements if the agency
does not even fully know the extent of their presence and effects
on consumers. Fortunately, the FDA can achieve a more robust
database with little extra funding. To begin with, the Federal
Food, Drug, and Cosmetic Act must be revised so that it requires
all dietary supplement companies to register themselves with the
FDA. Currently, some dietary supplement companies are exempt
from registration; the loopholes in the law that allow such
exemptions need to be ironed out. Specifically, the statue should
require companies who manufacture products exclusively
containing herbs to register themselves as supplement companies.
Furthermore, all dietary supplement companies should be
required to register detailed information about their products
with the FDA. Currently, companies only need to register the
names and locations of their firms.26 5 At the very least, companies
should be required to register the products they sell and their
products' ingredients. Finally, supplement companies should be
required to forward all adverse supplement-related reports they
receive, not just reports regarding mild and moderate events to
the FDA. Physicians should be required to report all supplement-
related incidents to the FDA as well.
The impact of the enhanced reporting and registration
requirements would be substantial. By requiring both businesses
and physicians to report all supplement-related side effects, the
FDA will have a much more complete and accurate picture of
how supplements are affecting the population. Such reporting
will allow the FDA to better identify pernicious trends in the
supplement industry and also allow the agency to more easily
take action to protect consumers. By having detailed information
regarding supplement companies' products and ingredients, the
FDA will be able to quickly and thoroughly take action to
identify and remove particular supplements and ingredients from
the market. Also, since companies will know that the FDA is
aware of their product's existence, the companies will be more
inclined to voluntarily remove their product from the market
before the FDA gets a chance to pursue legal action.
Not only would the enhanced reporting requirements
265 GAO, supra note 21, at 20.
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significantly improve the FDA's ability to police the dietary
supplement industry, but these requirements would also be
minimally burdensome for both the FDA and supplement
companies to implement. The FDA does not need to spend money
creating a new database or enhancing its enforcement regime to
process the influx of new information. Rather, the FDA just
needs to assimilate the information into its already-existing
central database. Similarly, the enhanced reporting requirements
will not put a terrible strain on businesses either. Businesses are
already required to take the time to register with the FDA and to
forward reports of serious adverse events they receive. Therefore,
most supplement companies should already have procedures in
place to carry out such duties. Simply requiring businesses to
report slightly more detailed information should not be
particularly costly or burdensome at all. Both the FDA and
supplement companies have gone through the onerous process of
initially implementing reporting and registration procedures;
now, they simply need to build upon the foundations they have
already put in place.
Grant Agencies Additional Enforcement Mechanisms.
Second, another relatively easy and inexpensive way to boost the
effectiveness of the regulatory regime is to give the FDA and
FTC a broader range of enforcement powers. Currently, both
agencies can essentially only purse onerous and expensive legal
battles to punish unscrupulous supplement companies. While
such battles are powerful enforcement mechanisms, it is simply
too costly to bring legal action against most violators.
Consequently, supplement companies do not fear actually being
caught and punished so they willfully violate government policy
in hopes of earning a profit.
One enforcement power the FDA and FTC should be
given is the ability to administer fines. Implementing fines would
not cost the government agencies very much time or money but
would give them substantially more enforcement power.
Depending on the severity of the fines, which could be increased
incrementally for repeat offenders, companies would be severely
punished for marketing deleterious products and using
misleading advertisements, and they would be strongly deterred
from engaging in future unscrupulous conduct. Furthermore, the
fines would not simply have an impact on the companies who
were caught. The fines would have a significant impact on
compliance rates throughout the entire industry. By having the
ability to dole out fines to offenders, the FDA and FTC would be
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able to punish far more unscrupulous companies than at present.
Each crooked company in the industry would have a greater
likelihood of being caught, and with this greater risk in mind,
many more companies would most likely decide that marketing
pernicious and ineffective products would not be worth the
gamble.
Furthermore, the FDA should be given the ability to issue
mandatory recalls. If the FDA identifies a product to be
potentially harmful, it should not be forced to negotiate with a
supplement company to recall the product or to go through the
arduous process of instituting a legal ban. Such a drawn-out
process leaves consumers exposed to products for long periods of
time even, after the FDA signals them to be deleterious. Instead,
it is in the best interest of consumers for the FDA to be able to
quickly and unilaterally remove a product from the market. By
having mandatory recall authority, the FDA could provide
expeditious consumer protection by removing a product from the
market immediately when the agency determines the supplement
to be harmful.
Together, the ability to administer fines and issue
mandatory recalls would give the FDA and FTC the ability to
take effective action against many more unscrupulous companies.
Giving the agencies these additional enforcement powers would
cost little, would strongly deter supplement companies from
marketing deleterious and ineffective products, and would help
ensure consumer safety.
Promote Consumer Understanding. Finally, the FDA and
FTC need to work together to improve consumer understanding
about the supplement industry. Currently, consumers do not
understand the structure of supplement industry regulation, and
this lack of knowledge is responsible for significant negative
consequences.
Consumers' general ignorance about supplement industry
regulation is dangerous because it can lead to a false sense of
security. If consumers think supplements are approved by the
FDA-an incorrect belief that a majority of consumers hold 2 66 -
then they will be less likely to conduct thorough personal research
about the supplements they are taking. Also, by believing that a
supplement has been approved as "safe" by the government,
consumers might be more likely to take powerful supplements
casually and copiously and disregard potentially serious side-
266 Id. at 8.
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effects. Consumer misunderstanding could potentially be
responsible for a large number of supplement-related injuries.26 7
For example, consider parents' willingness to give
supplements to their children. Major medical groups and
government agencies do not typically recommend supplements
for children who are otherwise healthy.2 68 However, a study by
the National Maternal and Infant Health Survey, published in
1997, found that fifty-four percent of parents give their preschool
children supplements at least three days a week.2 69 That statistic
might explain why injuries to children under six account for
nearly three-quarters of dietary supplement exposure reports.270 It
seems likely that parents do not even know about the
government's admonitions against giving supplements to
children. Many parents most likely do not fully understand the
risks involved with giving supplements to their children because
they erroneously believe that supplements have been
preapproved by the FDA. This misinformed belief that
government agencies approve supplements before they reach the
market appears to be making consumers more relaxed and less
cautious, which in turn leads to increased health risks.
While consumer ignorance will be a tough problem to
address, together the FDA and FTC can take several steps to
improve general understanding. At the least, consumers need to
understand that the FDA and FTC do not approve supplements
before they reach the market. Fortunately, there are several
relatively easy and inexpensive ways that the government can go
about educating consumers. First, the FTC could require all
supplement companies to put the DSHEA disclaimer-that the
supplement has not been evaluated by the FDA and that the
product is "not intended to diagnose, treat, cure or prevent any
disease" 27 1-on their advertisements. While the FTC's Business
Guide currently recommends the DSHEA disclaimer to be
included in some advertisements,2 72 the FTC could simply require
the disclaimer on all advertisements. Such a requirement would
expose consumers to the disclaimer more often so they would be
more likely to read it and absorb the information. Second, both
the FDA and FTC could require the DSHEA disclaimer to be
26? Hurley, supra note 250, at 2.
268 Id.
269 Id.
270 Id.
271 FTC Advertising Guide, supra note 95.
272 Id.
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more prominently pictured on both labels and advertisements.
Currently, disclaimers are often posted in very fine print on
portions of labels or advertisements that are not readily apparent.
Instead, the FDA and FTC could require large, bold disclaimers
in prominent locations. Such bold disclaimer requirements are
not unheard of: cigarette companies are already required to put
bold surgeon general warnings on their cigarette packages and
advertisements.27 3 Since supplements are harming so many
consumers, it might be wise to put a similarly bold disclaimer on
supplement labels and advertisements.
IV. Conclusion
Policing the dietary supplement industry is an incredibly
immense and onerous task. Together, the FDA, FTC and NAD
are constantly devising an array of innovative new strategies to
combat unscrupulous supplement companies and establish a safe
and honorable industry. While the public and private agencies
provide a robust regulatory force, it is currently insufficient to
protect consumers from deleterious products and misleading
advertisements. Fortunately, the FDA and FTC can take several
relatively inexpensive and minimally burdensome measures to
help augment consumer protection. However, for the time being,
consumers should still use caution when buying supplements and
should be aware of the current regulatory regime's shortcomings.
273 15 U.S.C. § 1331 (1965).
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